Business
CDC Contract Awarded by Queen Victoria Hospital
CDC Contract Awarded by Queen Victoria Hospital.
About this update from Feedback Plc
[{"type":"text","content":"\n\nFeedback plc\n \nFeedback Wins CDC Contract With Queen Victoria Hospital\n \nFeedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the clinical infrastructure specialist, is pleased to announce that it has been awarded a contract by Queen Victoria Hospital NHS Foundation Trust (\"QVH\") to provide its Bleepa Community Diagnostics Centre (\"CDC\") solution.\n \nThis contract, which is worth £495,000 for an initial 12-month term with the ability to extend by another 12 months, has been awarded to Feedback as the successful bidder in a procurement process launched by QVH in November 2023, to provide a digital infrastructure to facilitate patient specific pathways through the CDC, linking both primary and secondary care settings. \n \nFeedback has already delivered cost and time savings at QVH initially through its pilot programme. The pilot has provided a substantial reduction in wait time compared to the national 18-week referral-to-treatment (RTT) target, without the need for additional clinical staff. This contract award provides the opportunity for Feedback to continue to deliver the core digital infrastructure required for the CDCs to reduce the elective care backlog and deliver a programme for the maximum benefit of staff, patients and the wider NHS. The success of Bleepa at QVH provides a valuable case study for the wider market across the UK.\n \nDr Tom Oakley, CEO Feedback plc said:\n \n\"We are extremely pleased to announce that after two years of piloting our CDC solution with QVH we have been awarded a contract for the Bleepa platform. This contract will allow us to now expand the service offering to multiple GP practices and move beyond the breathlessness pathway to look at other specialty areas.\n \n\"This contract award is a compelling validation of our technology. QVH is an example that speaks to the rest of the NHS and is the pioneer of the symptom-based pathway on Bleepa, an approach which has demonstrated huge potential to cut wait times and improve care for patients. This contract will give others the confidence to progress with this care model and our platform, allowing us to now move forward to capture both the regional and national opportunity in front of us and ultimately to bring better, faster care to patients across the UK.\"\n \n \nThis announce...